November 25, 2016
November 25, 2016 - PRESSADVANTAGE -
TheProductLawyers.com reports on a recent communication from Immunovaccine that states their lead immuno-oncology product candidate has been granted Orphan Drug Designation.
According to a communication sent out by Immunovaccine, “The EMA grants Orphan Designation to medicines intended to treat, prevent or diagnose life threatening and debilitating disease, with a prevalence no greater than five in 10,000 in the EU and where no satisfactory method of treatment, prevention or diagnosis exists, unless the proposed medicine offers a significant benefit to those with the condition.” Recently, DPX-Survivac, a product designed to treat ovarian cancer, has received that status.
These progresses are pivotal to the treatment of ovarian cancer, especially for women in the U.S. are now also tangled in litigation concerning the cause of the deadly disease. Nearly 2,000 women who have opted to file lawsuits against companies such as Johnson & Johnson are alleging that their ovarian cancer is a result of using their talcum powder products. These plaintiffs state that after prolonged use of things such as Johnson & Johnson’s Baby Powder for feminine hygiene purposes, they were diagnosed with the deadly disease. These women are now claiming that a direct link exists between the two and that Johnson & Johnson knowingly marketed these products without warning consumers about the risks.
Johnson & Johnson has adamantly denied these claims and stated that they have “followed the science.” Studies over the last 40 years have been split on whether there is a connection between talcum powder and ovarian cancer. While some researchers have found an increased risk of cancer associated with talcum powders, others have found no such evidence.
Despite the lack of evidence, three juries have found that Johnson & Johnson can be held accountable for these women’s pain and suffering. Three trials so far have forced the company to pay millions in compensation to the women.
As these lawsuits are expected to grow in numbers, Banville Law is seeking to help those currently suffering. The firm has many years of experience fighting large pharmaceutical companies who have put dangerous drugs and devices onto the market, foregoing public safety for corporate greed. Attorneys at Banville Law want to assist those who believe they have been directly affected by the use of Johnson’s talcum powder. Affected individuals may be entitled to financial compensation and legal action. Banville Law is currently offering free consultations to individuals who qualify.
For more information, to schedule a consultation or to ask questions contact Banville Law at (888) 976-6742.
###
For more information about TheProductLawyers.com, contact the company here:
TheProductLawyers.com
Banville Law
888-478-9711
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023
TheProductLawyers.com is a resource website sponsored by Banville Law to provide information on pending lawsuits against defective products, drugs and medical devices.
Banville Law
165 West End Ave #1h,
New York, NY 10023
888-478-9711
info@banvillelaw.com
Visit Website
